nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylbutazone—SLC22A6—Hydrochlorothiazide—nephrolithiasis	0.58	1	CbGbCtD
Phenylbutazone—SLC22A11—Organic anion transport—SLC22A12—nephrolithiasis	0.0481	0.169	CbGpPWpGaD
Phenylbutazone—SLC22A8—Organic anion transport—SLC22A12—nephrolithiasis	0.0367	0.129	CbGpPWpGaD
Phenylbutazone—SLC22A6—Organic anion transport—SLC22A12—nephrolithiasis	0.0306	0.108	CbGpPWpGaD
Phenylbutazone—SLC22A11—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0224	0.0787	CbGpPWpGaD
Phenylbutazone—SLC22A8—nephron—nephrolithiasis	0.018	0.148	CbGeAlD
Phenylbutazone—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0171	0.06	CbGpPWpGaD
Phenylbutazone—SLC22A8—urine—nephrolithiasis	0.0144	0.118	CbGeAlD
Phenylbutazone—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0143	0.0501	CbGpPWpGaD
Phenylbutazone—Sulfinpyrazone—SLC22A12—nephrolithiasis	0.0136	1	CrCbGaD
Phenylbutazone—PTGS2—nephron—nephrolithiasis	0.0102	0.0837	CbGeAlD
Phenylbutazone—CYP2C9—urine—nephrolithiasis	0.00937	0.0769	CbGeAlD
Phenylbutazone—CYP3A4—urine—nephrolithiasis	0.00715	0.0587	CbGeAlD
Phenylbutazone—SLC22A11—nephron tubule—nephrolithiasis	0.00688	0.0565	CbGeAlD
Phenylbutazone—SLC22A6—nephron tubule—nephrolithiasis	0.00648	0.0532	CbGeAlD
Phenylbutazone—SLC22A11—renal system—nephrolithiasis	0.00625	0.0513	CbGeAlD
Phenylbutazone—SLC22A11—kidney—nephrolithiasis	0.00605	0.0496	CbGeAlD
Phenylbutazone—SLC22A11—cortex of kidney—nephrolithiasis	0.00589	0.0483	CbGeAlD
Phenylbutazone—SLC22A6—cortex of kidney—nephrolithiasis	0.00555	0.0455	CbGeAlD
Phenylbutazone—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00449	0.0158	CbGpPWpGaD
Phenylbutazone—PTGIS—Biological oxidations—SLC26A1—nephrolithiasis	0.00443	0.0155	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00417	0.0147	CbGpPWpGaD
Phenylbutazone—SLC22A8—nephron tubule—nephrolithiasis	0.00388	0.0319	CbGeAlD
Phenylbutazone—SLC22A8—renal system—nephrolithiasis	0.00353	0.029	CbGeAlD
Phenylbutazone—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00342	0.012	CbGpPWpGaD
Phenylbutazone—SLC22A8—kidney—nephrolithiasis	0.00341	0.028	CbGeAlD
Phenylbutazone—SLC22A8—cortex of kidney—nephrolithiasis	0.00332	0.0273	CbGeAlD
Phenylbutazone—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00318	0.0112	CbGpPWpGaD
Phenylbutazone—SLC22A11—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00294	0.0103	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00286	0.01	CbGpPWpGaD
Phenylbutazone—SLC22A11—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00269	0.00946	CbGpPWpGaD
Phenylbutazone—SLC22A11—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00269	0.00946	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00266	0.00933	CbGpPWpGaD
Phenylbutazone—SLC22A8—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00225	0.00788	CbGpPWpGaD
Phenylbutazone—PTGS1—renal system—nephrolithiasis	0.00209	0.0172	CbGeAlD
Phenylbutazone—SLC22A8—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00205	0.00721	CbGpPWpGaD
Phenylbutazone—SLC22A8—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00205	0.00721	CbGpPWpGaD
Phenylbutazone—SLC22A11—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00204	0.00717	CbGpPWpGaD
Phenylbutazone—SLC22A11—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00204	0.00717	CbGpPWpGaD
Phenylbutazone—PTGS1—kidney—nephrolithiasis	0.00202	0.0166	CbGeAlD
Phenylbutazone—PTGS2—renal system—nephrolithiasis	0.002	0.0164	CbGeAlD
Phenylbutazone—PTGS2—kidney—nephrolithiasis	0.00193	0.0159	CbGeAlD
Phenylbutazone—SLC22A11—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.0019	0.00666	CbGpPWpGaD
Phenylbutazone—SLC22A11—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.0019	0.00666	CbGpPWpGaD
Phenylbutazone—SLC22A6—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00187	0.00658	CbGpPWpGaD
Phenylbutazone—CYP3A4—renal system—nephrolithiasis	0.00175	0.0144	CbGeAlD
Phenylbutazone—SLC22A6—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00171	0.00602	CbGpPWpGaD
Phenylbutazone—SLC22A6—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00171	0.00602	CbGpPWpGaD
Phenylbutazone—SLC22A11—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00169	0.00594	CbGpPWpGaD
Phenylbutazone—CYP3A4—kidney—nephrolithiasis	0.00169	0.0139	CbGeAlD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00168	0.00589	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00168	0.00589	CbGpPWpGaD
Phenylbutazone—SLC22A8—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00156	0.00546	CbGpPWpGaD
Phenylbutazone—SLC22A8—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00156	0.00546	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.0015	0.00525	CbGpPWpGaD
Phenylbutazone—SLC22A8—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00145	0.00508	CbGpPWpGaD
Phenylbutazone—SLC22A8—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00145	0.00508	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00137	0.0048	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00137	0.0048	CbGpPWpGaD
Phenylbutazone—PTGS1—Biological oxidations—SLC26A1—nephrolithiasis	0.00136	0.00478	CbGpPWpGaD
Phenylbutazone—SLC22A6—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.0013	0.00456	CbGpPWpGaD
Phenylbutazone—SLC22A6—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.0013	0.00456	CbGpPWpGaD
Phenylbutazone—SLC22A8—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00129	0.00453	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00128	0.0045	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00128	0.0045	CbGpPWpGaD
Phenylbutazone—SLC22A6—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00121	0.00424	CbGpPWpGaD
Phenylbutazone—SLC22A6—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00121	0.00424	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00114	0.00401	CbGpPWpGaD
Phenylbutazone—SLC22A6—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00108	0.00378	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00107	0.00375	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00107	0.00375	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00104	0.00366	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00104	0.00366	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—AQP1—nephrolithiasis	0.00104	0.00365	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00104	0.00364	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00104	0.00364	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—GRHPR—nephrolithiasis	0.000999	0.00351	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000964	0.00339	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000964	0.00339	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000952	0.00334	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—SLC26A1—nephrolithiasis	0.000904	0.00317	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—AGXT—nephrolithiasis	0.00089	0.00313	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000871	0.00306	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000871	0.00306	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000859	0.00302	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000859	0.00302	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—ATP6V0A4—nephrolithiasis	0.000805	0.00283	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000791	0.00278	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000791	0.00278	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—SLC26A1—nephrolithiasis	0.000757	0.00266	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—APRT—nephrolithiasis	0.000757	0.00266	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000735	0.00258	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000735	0.00258	CbGpPWpGaD
Phenylbutazone—CYP2C9—Biological oxidations—SLC26A1—nephrolithiasis	0.000715	0.00251	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000687	0.00241	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00066	0.00232	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00066	0.00232	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000655	0.0023	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000655	0.0023	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000614	0.00215	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000614	0.00215	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000547	0.00192	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000547	0.00192	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—AQP1—nephrolithiasis	0.000539	0.00189	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000524	0.00184	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—CHRM3—nephrolithiasis	0.000488	0.00171	CbGpPWpGaD
Phenylbutazone—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.000472	0.00166	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000437	0.00154	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GRHPR—nephrolithiasis	0.000307	0.00108	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—AGXT—nephrolithiasis	0.000274	0.000961	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GRHPR—nephrolithiasis	0.000244	0.000856	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—APRT—nephrolithiasis	0.000233	0.000817	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—SLC26A1—nephrolithiasis	0.000233	0.000817	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—SLC26A1—nephrolithiasis	0.00022	0.000774	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—AGXT—nephrolithiasis	0.000217	0.000763	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—ATP6V0A4—nephrolithiasis	0.000197	0.00069	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—SLC26A1—nephrolithiasis	0.000185	0.000648	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—APRT—nephrolithiasis	0.000185	0.000648	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—AQP1—nephrolithiasis	0.000166	0.000582	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GRHPR—nephrolithiasis	0.000161	0.000567	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CHRM3—nephrolithiasis	0.00015	0.000526	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—AGXT—nephrolithiasis	0.000144	0.000505	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—AQP1—nephrolithiasis	0.000132	0.000462	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SLC26A1—nephrolithiasis	0.000122	0.000429	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—APRT—nephrolithiasis	0.000122	0.000429	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CHRM3—nephrolithiasis	0.000119	0.000418	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.000106	0.000374	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—AGXT—nephrolithiasis	9.48e-05	0.000333	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—AQP1—nephrolithiasis	8.71e-05	0.000306	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	8.06e-05	0.000283	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—APRT—nephrolithiasis	8.06e-05	0.000283	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CHRM3—nephrolithiasis	7.88e-05	0.000277	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—AQP1—nephrolithiasis	5.75e-05	0.000202	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CHRM3—nephrolithiasis	5.2e-05	0.000182	CbGpPWpGaD
